Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Asset Writedowns and Impairment (2022 - 2025)

Orthopediatrics (KIDS) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 27.94% to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.2 million, a 83.27% increase, with the full-year FY2025 number at $6.5 million, up 254.68% from a year prior.
  • Asset Writedowns and Impairment was $2.3 million for Q4 2025 at Orthopediatrics, up from $1.8 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.3 million in Q4 2025 to a low of $985000.0 in Q3 2023.
  • A 3-year average of $1.7 million and a median of $1.8 million in 2024 define the central range for Asset Writedowns and Impairment.
  • Biggest YoY gain for Asset Writedowns and Impairment was 27.94% in 2025; the steepest drop was 27.94% in 2025.
  • Orthopediatrics' Asset Writedowns and Impairment stood at $985000.0 in 2023, then surged by 86.4% to $1.8 million in 2024, then rose by 27.94% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Asset Writedowns and Impairment are $2.3 million (Q4 2025), $1.8 million (Q4 2024), and $985000.0 (Q3 2023).